Epicrispr Biotechnologies
Pre-clinicalDeveloping therapies to dynamically control gene expression and treat complex disease
Founded
2018
Focus
CRISPRGene Therapy
About
Developing therapies to dynamically control gene expression and treat complex disease
Funding History
1Total raised: $5.5M
Seed$5.5MUndisclosedJun 15, 2023
Company Info
TypePrivate
Founded2018
LocationCambridge, United States
StagePre-clinical
Contact
Sectors
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile